STAT+: Pfizer’s gene therapy for Duchenne muscular dystrophy fails in phase 3 trial
Pfizer said Wednesday afternoon that a closely watched gene therapy for Duchenne muscular dystrophy failed…
Category: research
What do Parkinson’s and obesity have in common?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Three scientists win Kavli Prize for nanoscience in biomedicine
Three scientists — Robert Langer, Paul Alivisatos, and Chad Mirkin — were awarded the 2024…
House Republicans press for new guardrails on ‘gain-of-function’ research by NIH
WASHINGTON — Republican leaders of a prominent committee overseeing federal health agencies are pushing to…
Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Medical device trials still don’t enroll enough women, study finds
Women have always been underrepresented in medical research. A new study reveals that not much…
Millions fewer people may need statins, a new study suggests. But guidelines have yet to agree
It’s a familiar scene for patients during a routine primary care visit. The doctor scans…
NIH will bring clinical research into primary care offices with $30 million pilot
For many Americans, health care means going to a local primary care office. But the…
Vanda Pharmaceuticals has another suitor
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Stephen Quake on the Chan Zuckerberg quest to cure, prevent, or manage all diseases by 2100
SAN DIEGO — Decades ago, as a young physics Ph.D. student, Stephen Quake stumbled into…
Novovax will be able to supply Covid-19 vaccines this fall
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Withdrawal symptoms hit one in six patients stopping antidepressants, review finds
The moment when a person stops taking their antidepressant is fraught. Not only can patients…
Opinion: 100,000 models show that not much was learned about stopping the Covid-19 pandemic
In the midst of the Covid-19 pandemic, scientists and public health institutions made bold claims…
Testing begins for a new form of PrEP
Want to stay on top of the science and politics driving biotech today? Sign up to get…
ASCO Takeaways: Winners, snoozers, the China question and the art of cancer care
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American…
Operation Warp Speed but for rare disease
Want to stay on top of the science and politics driving biotech today? Sign up to get…
A new discovery about carbon dioxide is challenging decades-old ventilation doctrine
Carbon dioxide monitors have been around for decades. But in 2020, they became, almost overnight,…
STAT+: Leading CRO to pay record fine for badly neglecting hundreds of beagles in breeding facility
A leading contract research organization has agreed to pay $35 million — including the largest-ever…
STAT+: At ASCO, AstraZeneca says its CAR-T therapy shrank solid liver tumors in early trial
CHICAGO — A next-generation CAR-T therapy was able to substantially shrink tumors in patients with…
Can AstraZeneca make good on its promise?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What to watch for in the crucial FDA meeting on MDMA therapy for PTSD
In less than three months, the Food and Drug Administration will decide whether to approve…
The surprising outperformance of a new drug against existing competitors, and other biotech updates
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Ionis drug prevents swelling attacks caused by rare genetic disease in late-stage trials
Ionis Pharmaceuticals, a California company that pioneered a whole class of RNA-targeted medicines, reported on…
NIH documents show how $1.6 billion long Covid initiative has failed so far to meet its goals
More than three years ago, the National Institutes of Health launched a $1 billion-plus initiative…
Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What the rescheduling of marijuana might — and might not — mean for scientific research
WASHINGTON — After years of inertia, the field of research into the health effects of…
NIH-funded clinical trials often miss racial, gender diversity enrollment goals, report finds
WASHINGTON — Clinical trials that the National Institutes of Health funds often enroll fewer Black…
.jpg)
Wegovy linked to lower risk of alcohol use disorder in real-world study
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Biotech’s most interesting fundraisings from the last week
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Gene therapies for deafness dredge up an old question: Do deaf people want a ‘cure’?
When Yilai Shu was training to be an otolaryngologist in Shanghai, in the mid 2000s,…
New evidence supports fear that drinking raw milk containing bird flu viruses may be dangerous
A new study published Friday provides more evidence of the potential danger of drinking unpasteurized,…
More tumult at BIO amid the company’s fourth CEO in four years
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The HPV vaccine prevents cancer in men, too. Why do so few people get it?
You’d think if there were a vaccine that would prevent tens of thousands of cases…
In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Biotechs turn to gene silencing for obesity drugs that can last longer than Wegovy
Enticed by the immense market opened by GLP-1 weight loss drugs Wegovy and Zepbound, a…
Maryland takes first steps to cap drug costs
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Listen: A conversation with researcher Kevin Esvelt on the urgency of improving biosecurity measures
If you ask a chatbot how to cause a pandemic, it will suggest the 1918…
Opinion: What clinical real-world data can deliver
Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs…
Lilly doubles down on radiopharma
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Removing race adjustment from lung test could mean higher disability payments for Black vets
Removing a patient’s race from an equation used to assess lung function — a change…
AstraZeneca antibody reduced Covid-19 risk in immunocompromised
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Data integrity watchdogs call for stronger safeguards in scientific journals
SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of…
STAT+: To bolster global health, Wellcome Trust’s new CEO thinks Big Tech should get involved
LONDON — The key groups involved in addressing global health problems often include governments, foundations,…
In military medicine, study shows rank and race affect care
Higher ranking military officers receive more resources and better care than low ranking military officers,…
STAT+: Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers
When it comes to bringing an experimental drug to market and selling it, Novo Nordisk,…
Blackstone wants in on red-hot immunology market
The need-to-know this morning Biogen and Ionis Pharmaceuticals are ending their development of an experimental drug for ALS based on…
STAT+: Getting abortion pills through the mail is safe, quick, and effective, study finds
Amid a national furor over access to abortion, a new study found that dispensing abortion…
HHS suspends federal funding for EcoHealth Alliance
WASHINGTON — The Biden administration has suspended federal grants issued to EcoHealth Alliance, the infectious…
Leqembi gets closer to being offered as an injection
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Is Novavax a new meme stock?
Want to stay on top of the science and politics driving biotech today? Sign up to get…